Optimal image sampling schedule for both image-derived input and output functions in PET cardiac studies

IEEE Trans Med Imaging. 2000 Mar;19(3):233-42. doi: 10.1109/42.845181.

Abstract

Optimal sampling schedule (OSS) design for both image-derived input and output functions in tracer kinetic modeling with positron emission tomography (PET) is investigated. This problem is very important in noninvasive PET dynamic cardiac studies where both the input function, i.e., the plasma time-activity curve (PTAC), and the output function, i.e., the tissue time-activity curve (TTAC), are obtained simultaneously from the same sequence of PET images. The integral PET measurement is used in this study. The spillover correction for the cross contaminations in cardiac studies is incorporated into the OSS design procedure. A new target function based on the D-optimal criterion involving both the input and output sensitivity functions is proposed. The fluorodeoxyglucose (FDG) model and a six-parameter PTAC model are used to illustrate the simultaneous OSS design for both the PTAC and TTAC. An OSS design consisting of six different scanning intervals is derived. Computer simulations are performed based on the estimated parameters from real studies to evaluate the effectiveness of the OSS. The double modeling approach is used in parameter estimation to simultaneously estimate the parameters involved. The results have shown that, for a wide range of parameter variations, the OSS is as effective as a conventional sampling schedule (CSS) and comparable parameter estimates can be obtained. Compared with the use of the CSS, the use of the OSS leads to an approximately 70% reduction in the storage space and data processing time.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computer Simulation
  • Fluorodeoxyglucose F18
  • Heart / diagnostic imaging*
  • Heart / physiology
  • Humans
  • Myocardial Contraction / physiology
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Tomography, Emission-Computed / methods*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18